Pathophysiology of beta2-glycoprotein I in antiphospholipid syndrome. - Wikidata - awgldk - TriplyDB

Pathophysiology of beta2-glycoprotein I in antiphospholipid syndrome.

Pathophysiology of beta2-glycoprotein I in antiphospholipid syndrome.

http://www.wikidata.org/entity/Q37721597

about

Circulating Immune Complexes of IgA Bound to Beta 2 Glycoprotein are Strongly Associated with the Occurrence of Acute Thrombotic Events Autoantibodies directed against domain I of beta2-glycoprotein I.Influenza vaccination can induce new-onset anticardiolipins but not β2-glycoprotein-I antibodies among patients with systemic lupus erythematosus.Dendritic cells: an important link between antiphospholipid antibodies, endothelial dysfunction, and atherosclerosis in autoimmune and non-autoimmune diseases.Immunotherapeutic strategies in antiphospholipid syndrome.β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome.Isolated anti-β2-glycoprotein I antibodies in neurology: a frontier syndrome between multiple sclerosis and antiphospholipid syndrome?

P2860

Q33431396-2CE25B76-0645-4A1C-8980-E913AFE6453F Q34467454-CA2E5101-DAA5-4936-8AE7-FABD3994CF4B Q35711767-E15F55A7-427B-4AF1-B91A-AAA4EFCEB945 Q38078691-177B97F2-72AD-4209-A5EC-2CB500E57D60 Q38826804-8A9FE2AE-EF53-430B-8903-3F3E1EF3012F Q48243949-E9AFB7BA-B557-4F1D-A1DB-3C65AED21009 Q50702531-E3E10ED2-F260-4BFD-B190-AECF377543EB

P2860

Pathophysiology of beta2-glycoprotein I in antiphospholipid syndrome.

http://www.wikidata.org/entity/Q37721597

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on April 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Pathophysiology of beta2-glycoprotein I in antiphospholipid syndrome.

@en

Pathophysiology of beta2-glycoprotein I in antiphospholipid syndrome.

@nl

type

label

Pathophysiology of beta2-glycoprotein I in antiphospholipid syndrome.

@en

Pathophysiology of beta2-glycoprotein I in antiphospholipid syndrome.

@nl

prefLabel

Pathophysiology of beta2-glycoprotein I in antiphospholipid syndrome.

@en

Pathophysiology of beta2-glycoprotein I in antiphospholipid syndrome.

@nl

P1433

Q37721597-915D9489-4F31-4D43-A50B-699878349918

P1476

Q37721597-07123078-75CC-41BB-B608-F0611E48B838

P2093

Q37721597-11A25274-8308-462A-B950-853EE90A1498

Q37721597-1432B136-8EC0-4C9B-93E1-3C688E3E0ADE

Q37721597-193ACC6E-F8DC-4BF5-895F-E2986058EE11

Q37721597-29283109-9A7D-4356-88DD-EB7EC1BF6C8F

Q37721597-6746DBD1-1BE5-475C-888D-157BBA8E14F4

Q37721597-B1A89C69-C80D-4758-9DEB-F3542522A7DE

Q37721597-B5BA27E8-ECA9-4E7F-B1DD-D3FEAE3B2D59

Q37721597-D32820A0-8E56-45E8-A49C-AE983E33F2A2

Q37721597-F6F33546-FBD3-4E72-8DB9-E9377ED4CC81

P2860

Q37721597-0DEA3CF7-FA53-4365-AE9C-2823AE3518F1

Q37721597-12F6BB05-D116-416C-AF5A-C316CCCAC12A

Q37721597-163108A1-A1A9-4DA8-8D92-FC4BBC51F1D8

Q37721597-38B9BB9C-2C22-4D8F-907B-A09A919B5792

Q37721597-46A9C2C5-2302-4406-AF2A-B8AE43923662

Q37721597-63088272-E73B-4BB2-A642-CD11C30F1329

Q37721597-66F99FDC-FB15-4440-B746-388E77A5F5EF

Q37721597-68E412F1-AC05-43BB-B974-77BE018D43A5

Q37721597-6A1882EE-B2A4-49E8-B180-9F87FE5539F9

Q37721597-6D1899E5-7DFE-4E16-A61C-04D8954C0A26

P304

Q37721597-6D74C980-DAB7-4B73-8A76-4A5155780EB2

P31

Q37721597-9367348B-0B0B-48A0-A53E-84C20FD0694E

P356

Q37721597-B06BE28C-15FB-4F20-8DEF-C1AD6911CF68

P433

Q37721597-0016E67C-AE6B-48A0-AA44-6CC9D13DC97C

P478

Q37721597-FEDE2288-58B0-45F4-9853-56E8BB3AE5D2

P50

Q37721597-63FDA754-A01E-4CF6-84CB-A389BA12E88D

P577

Q37721597-22303710-51D3-4D19-9CD8-A5F67C24D4DA

P698

Q37721597-1698B78A-314F-4CA8-AC70-74C0AAA8E78C

P921

Q37721597-50DCA110-0E0F-4526-A54F-72D4DE6B5CD0

P356

0961203310361352

P1433

P1476

Pathophysiology of beta2-glycoprotein I in antiphospholipid syndrome.

@en

P2093

F J Geske

http://www.w3.org/2001/XMLSchema#string

K Kobayashi

http://www.w3.org/2001/XMLSchema#string

L R Lopez

http://www.w3.org/2001/XMLSchema#string

L Shen

http://www.w3.org/2001/XMLSchema#string

M Boisen

http://www.w3.org/2001/XMLSchema#string

M Makarova

http://www.w3.org/2001/XMLSchema#string

N Quan

http://www.w3.org/2001/XMLSchema#string

S Yasuda

http://www.w3.org/2001/XMLSchema#string

Y Matsunami

http://www.w3.org/2001/XMLSchema#string

P2860

Nicked beta2-glycoprotein I: a marker of cerebral infarct and a novel role in the negative feedback pathway of extrinsic fibrinolysis

Kringle domains of human angiostatin. Characterization of the anti-proliferative activity on endothelial cells

Anti-beta2-glycoprotein I (beta2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the beta2GPI binding to phospholipids

Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure.

Crystal structure of human β2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome

Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2'

Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies

Prothrombinase activity of human platelets is inhibited by beta 2-glycoprotein-I

Impaired thrombin generation in beta 2-glycoprotein I null mice

Angiogenesis in cancer, vascular, rheumatoid and other disease

P304

379-384

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0961203310361352

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20353973

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology